Bruker (BRKR) Return on Capital Employed (2011 - 2026)
Bruker (BRKR) posted Return on Capital Employed of 0.96% for Q1 2026, down 28.45% on a QoQ basis from 1.35% in Q4 2025, and down 390.0% year-over-year from 0.33% in Q1 2025.
Bruker (BRKR) Return on Capital Employed (2011 - 2026) Analysis & Trends
Bruker's Return on Capital Employed history runs 16 years deep, the most recent figure standing at 0.96% for Q1 2026.
- Quarterly Return on Capital Employed fell 390.0% year-over-year to 0.96% in Q1 2026, while the trailing twelve-month figure through Mar 2026 was 0.96% (down 390.0% YoY) and the FY2025 annual result came in at 1.44%, down 532.0% from the prior year.
- Return on Capital Employed was 0.96% for Q1 2026 at Bruker, down from 1.35% in the prior quarter.
- Across five years, Return on Capital Employed topped out at 17.39% in Q1 2023 and bottomed at 0.96% in Q1 2026.
- A 5-year average of 10.35% and a median of 11.86% in 2024 frame the typical range for Return on Capital Employed.
- Annual changes were most pronounced in 2023 — Return on Capital Employed soared 192 bps — and 2024, when it slumped 1072 bps.
- Bruker's Return on Capital Employed stood at 16.9% in 2022, then dropped by 9 bps to 15.42% in 2023, then slumped by 65 bps to 5.41% in 2024, then tumbled by 75 bps to 1.35% in 2025, then decreased by 28 bps to 0.96% in 2026.
- Business Quant data shows BRKR's Return on Capital Employed at 0.96% in Q1 2026, 1.35% in Q4 2025, and 1.25% in Q3 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | ROCE (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 183.91 Bn | 176.62 Bn | 6.27 Bn | 9.61% |
| 2 | Stryker | 128.87 Bn | 125.99 Bn | 3.81 Bn | 12.24% |
| 3 | Medtronic | 108.72 Bn | 99.50 Bn | 6.41 Bn | 8.02% |
| 4 | Boston Scientific | 68.46 Bn | 67.01 Bn | 3.61 Bn | 9.62% |
| 5 | Edwards Lifesciences | 48.53 Bn | 44.85 Bn | 1.29 Bn | 11.13% |
| 6 | Dexcom | 28.37 Bn | 27.25 Bn | 750.30 Mn | 24.24% |
| 7 | GE HealthCare Technologies | 28.34 Bn | 26.06 Bn | 1.98 Bn | 9.30% |
| 8 | Smith & Nephew | 26.91 Bn | 26.33 Bn | - | - |
| 9 | Koninklijke Philips | 25.47 Bn | 22.34 Bn | 2.07 Bn | 8.38% |
| 10 | Bruker | 9.16 Bn | 9.16 Bn | 379.80 Mn | 0.96% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 0.96% |
| Dec 31, 2025 | 1.35% |
| Sep 30, 2025 | 1.25% |
| Jun 30, 2025 | 3.84% |
| Mar 31, 2025 | 4.86% |
| Dec 31, 2024 | 5.41% |
| Sep 30, 2024 | 6.07% |
| Jun 30, 2024 | 8.74% |
| Mar 31, 2024 | 11.86% |
| Dec 31, 2023 | 15.42% |
| Sep 30, 2023 | 16.79% |
| Jun 30, 2023 | 17.08% |
| Mar 31, 2023 | 17.39% |
| Dec 31, 2022 | 16.90% |
| Sep 30, 2022 | 17.11% |
| Jun 30, 2022 | 15.44% |
| Mar 31, 2022 | 15.47% |
| Dec 31, 2021 | 16.87% |
| Sep 30, 2021 | 18.33% |
| Jun 30, 2021 | 17.50% |